BrightSpring Health Services, Inc. Common Stock (BTSG)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $14.20B
Last updated: Nov 17, 2026 at 4:33 PM ET
BrightSpring Health Services, Inc. Common Stock (BTSG) Statistics
BrightSpring Health Services, Inc. Common Stock (BTSG) has a market cap of $14.20B and an enterprise value of $15.81B. Revenue grew 25.97% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 11.33% above the market cap, as debt exceeds cash.
| Market Cap | $14.20B |
|---|---|
| Enterprise Value | $15.81B |
| Latest price (Nov 17, 2026) | $69.83 |
Key Dates
The next earnings report is expected on Feb 25, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 25, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 30, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.9x and 6.6x.
| P/E Ratio | 40.8x |
|---|---|
| Forward P/E | 36.5x |
| P/S Ratio | 0.9x |
| Forward P/S | 0.9x |
| P/B Ratio | 6.6x |
| P/FCF Ratio | 29.4x |
| P/OCF Ratio | 23.6x |
| PEG Ratio | 1.1 |
Enterprise Valuation
Counting debt and cash, the company is valued at 23.3x EBITDA and 32.6x free cash flow.
| EV / Earnings | 38.5x |
|---|---|
| EV / Sales | 1.0x |
| EV / EBITDA | 23.3x |
| EV / EBIT | 30.4x |
| EV / FCF | 32.6x |
Price Statistics
The stock is up 118.22% over 52 weeks and trades 12.10% above its 50-day average.
| Beta (1Y) | 1.04 |
|---|---|
| 52-Week Change | +118.22% |
| 1-Month Change | +13.93% |
| 3-Month Change | +17.70% |
| 6-Month Change | +23.11% |
| Total Return (1Y) | +118.22% |
| Return vs SPY (1Y) | +109.77% |
| Max Drawdown (1Y) | -23.62% |
| Max Drawdown (3Y) | -35.56% |
| Sharpe Ratio (1Y) | 1.75 |
| Correlation with SPY (1Y) | 0.32 |
| 50-Day Average | $62.29 |
| 200-Day Average | $56.50 |
| 52-Week Range | $31.42 to $73.75 |
| RSI (14 Days) | 59.9 |
| Average Volume (20 Days) | 2.76M |
Financial Position
Current assets cover 1.62x current liabilities, and total debt is 1.07x shareholder equity.
| Current Ratio | 1.62x |
|---|---|
| Quick Ratio | 1.22x |
| Debt / Equity | 1.07x |
| Debt / EBITDA | 3.37x |
| Debt / FCF | 4.73x |
| Interest Coverage | 3.59x |
Returns and Efficiency
Return on invested capital is 9.58% and return on equity is 18.86% over the last 12 months.
| Return on Equity (ROE) | 18.86% |
|---|---|
| Return on Assets (ROA) | 6.55% |
| Return on Invested Capital (ROIC) | 9.58% |
| Return on Capital Employed (ROCE) | 11.42% |
| ROE (5Y Average) | -3.75% |
| ROA (5Y Average) | -0.07% |
| Asset Turnover | 2.48x |
| Inventory Turnover | 21.41x |
| Receivables Turnover | 12.95x |
| Cash Conversion Cycle | 13 days |
Taxes
Income tax took 17.08% of pretax income over the last 12 months.
| Income Tax (TTM) | $64.13M |
|---|---|
| Effective Tax Rate | 17.08% |
Scores
BTSG has an Altman Z-Score of 5.07, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.07 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $15.25B over the last 12 months.
| Revenue | $15.25B |
|---|---|
| Revenue Growth (YoY) | +25.97% |
| Gross Profit | $1.91B |
| Operating Income | $520.43M |
| Pretax Income | $375.37M |
| Net Income | $410.44M |
| EBITDA | $690.02M |
| EBIT | $520.43M |
| Reported EPS (TTM) | $1.71 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 34.77% of the $6.27B in total assets.
| Cash and Equivalents | $717.84M |
|---|---|
| Total Debt | $2.33B |
| Net Debt | $1.61B |
| Net Debt Per Share | $7.77 |
| Working Capital | $1.05B |
| Shareholder Equity | $2.18B |
| Book Value Per Share | $10.51 |
| Tangible Book Value | -$852.25M |
| Total Assets | $6.27B |
| Total Liabilities | $4.08B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $110.33M of capital spending, operating cash flow left $492.41M of free cash flow.
| Operating Cash Flow | $602.74M |
|---|---|
| Capital Expenditures | $110.33M |
| Free Cash Flow | $492.41M |
| FCF Per Share | $2.49 |
| Depreciation and Amortization | $169.59M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 3.41%, against a 5-year average of 2.01%.
| Gross Margin | 12.50% |
|---|---|
| Operating Margin | 3.41% |
| Pretax Margin | 2.46% |
| Net Margin | 2.69% |
| EBITDA Margin | 4.52% |
| EBIT Margin | 3.41% |
| FCF Margin | 3.23% |
| Gross Margin (5Y Average) | 15.06% |
| Operating Margin (5Y Average) | 2.01% |
| Net Margin (5Y Average) | -0.15% |
Growth
Revenue grew 18.69% a year over 3 years.
| Revenue Growth (3Y CAGR) | +18.69% |
|---|---|
| Revenue Growth (5Y CAGR) | +18.27% |
| FCF Growth (5Y CAGR) | +18.25% |
| Operating Income Growth (3Y CAGR) | +16.27% |
| Book Value Per Share Growth (2Y CAGR) | +58.53% |
Dividends and Yields
BTSG does not pay a dividend. Its free cash flow yield is 3.41%.
| Earnings Yield | 2.45% |
|---|---|
| FCF Yield | 3.41% |
| Buyback Yield | 0.80% |
| Shareholder Yield | 0.80% |
Peer Position
Against 8 similar companies, BTSG has the 3rd highest P/E.
P/E RatioPeer median 31.4x
P/S RatioPeer median 7.6x
ROICPeer median -3.51%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +16.50%
| P/E Ratio | 40.8x vs 31.4x median |
|---|---|
| P/S Ratio | 0.9x vs 7.6x median |
| ROIC | 9.58% vs -3.51% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +25.97% vs +16.50% median |
Analyst Forecast
Consensus estimates put revenue growth at 19.45% and EPS growth at 52.84% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +19.45% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +52.84% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BTSG
What is BTSG's market cap?
BrightSpring Health Services, Inc. Common Stock has a market cap of $14.20B. Its enterprise value, which adds debt and subtracts cash, is $15.81B.
What is BTSG's P/E ratio?
BrightSpring Health Services, Inc. Common Stock has a trailing P/E ratio of 40.8x and a forward P/E of 36.5x.
How many shares of BTSG are outstanding?
BrightSpring Health Services, Inc. Common Stock has 207.02M shares outstanding. The count is up 1.74% from a year earlier.
Does BTSG pay a dividend?
No. BrightSpring Health Services, Inc. Common Stock does not pay a dividend.
How much debt does BTSG have?
BrightSpring Health Services, Inc. Common Stock has $2.33B of total debt and $717.84M of cash and equivalents, a net debt position of $1.61B.
BTSG pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors